Abstract:
Derivatives of formula: ##STR1## in which Z N-R.sub.1 where R.sub.1 represents a linear or branched alkyl group with 1 to 5 carbon atoms or a phenyl group possibly substituted by a chlorine atom, in which case:n=1 or 2,the pair (A, C X) assumes the following values: (S, C.dbd.O), (S, CH.sub.2), (O, CH.sub.2), (O, CH--C.sub.6 H.sub.5), andR represents a hydrogen or halogen atom, one or more methoxy groups or the butadiene-1,3 ylene chain ##STR2## fixed in position 5,6 of the phenyhl nucleus and thus forming with this latter a naphthyl nucleus;or a methylene group (--CH.sub.2 --), in which case:n=1 or 2,A represents the oxygen atom,>C X represents a carbonyl group (>C.dbd.O) or thiocarbonyl group (>C.dbd.S), andR has the same meanings as previously,as well as the mineral or organic acid addition salts thereof. The compounds exhibit anti-convulsion and analgesic activity.
Abstract translation:式:其中Z <表示:其中R1表示具有1-5个碳原子的直链或支链烷基或可能被氯原子取代的苯基,其中Z <表示:结构的氨基> N-R1的衍生物, (S,C = O),(S,CH 2),(O,CH 2),(O,CH-C 6 H 5)和 R表示氢或卤素原子,一个或多个甲氧基或固定在苯基核的5,6位的丁二烯-1,3-亚苯基链,因此与后者形成萘基核; 或亚甲基(-CH 2 - ),在这种情况下:n = 1或2,A表示氧原子,> CX表示羰基(> C = O)或硫代羰基(> C = S),R 具有与之前相同的含义,以及其矿物或有机酸加成盐。 该化合物表现出抗惊厥和止痛活性。
Abstract:
Derivatives of 5H-furanone-2 and 3H-dihydrofuranone-2, substituted at the 3 position with substituted phenyl and at the 5 position with substituted methyl, are prepared by various processes. The derivatives are inhibitors of monoamine oxidase and are useful for treating depression.
Abstract:
N-aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones are disclosed. These compounds possess antidepressant activity.
Abstract:
In a control grid for an electron tube, the grid has first bars that are evenly spaced out on a skewed surface and extend substantially as circle pseudo-involutes about a central hub.
Abstract:
The present invention relates to novel compounds, the preparation and use, particularly therapeutic, thereof. More specifically, it relates to compounds derived from aryl carbamates, the preparation and use thereof, particularly in the field of human and animal health. The compounds according to the invention are preferably 5-HT4 serotoninergic receptor ligands and can therefore be used in the therapeutic or prophylactic treatment of any disorder involving a 5-HT4 receptor. The invention also relates to pharmaceutical compositions comprising such compounds, the preparation and use thereof and treatment methods using said compounds. Compounds according to the invention include compounds of the following formula (I):
Abstract:
The invention concerns compounds of formula (I): R—A—R′ wherein: A is as defined in the description; R represents a group (V), (VI), (VII) or (VIII), where E, Q, R1, R2, R3, v and R4 are as defined in the description; R′ represents a —(CH2)t-R5 group wherein t and R5 are as defined in the description.
Abstract:
The present invention pertains to an amplification device for a high-frequency signal. The invention is particularly adapted for the transmission of radiofrequency signals used for television of radio under frequency modulation. The amplification device for a high-frequency signal comprises of two amplification stages arranged in series, the first amplification stage being formed of a semiconductor preamplifier, the second amplification stage being formed of an electron tube cooled by the circulation of a fluid, the electron tube being arranged inside an enclosure intended to receive it. The semiconductor preamplifier is arranged in the enclosure and the preamplifier is cooled by the circulation of the fluid. The electron tube comprises a collector needing to be cooled by the circulation of the fluid, and the fluid circulates around a cooling circuit, in which the collector is connected in parallel with the preamplifier.
Abstract:
The invention concerns compounds of formula (I): R—A—R′ wherein: A is as defined in the description; R represent, a group (V), wherein R′a and R″a are as defined in the description, or R forms with A a cyclic structure as defined in the description; R′ represents a (CH2)t—R2 group wherein q, t, and R2 are as defined in the description. The invention is useful for preparing medicines.
Abstract:
The invention concerns compounds of formula (I) in which: A forms a tricyclic system of formula A1, A2, A3 or A4; R1 represents a hydrogen atom, an alkyl, hydroxy, alkoxy or oxo group; (R2)m and (R3)m′ are such as defined in the description; n represents an integer such that 0≦n≦3; p represents an integer such as defined in the description; B represents a group (a) or (b). The invention is useful for preparing medicines.
Abstract:
A resonant cavity (49) which facilitates coupling to another resonant cavity includes walls (40, 42) and an electrically conducting mast (43). One of the walls (40) has a coupling orifice (41) for coupling the resonant cavity (49) to another resonant cavity. The electrically conducting mast (43) projects from the second wall (42) opposite the first wall (40) and faces the coupling orifice (41). The electrically conducting mast (43) terminates with a hook-shaped portion (44) which contacts an edge of the coupling orifice (41). The resonant cavity (49) is suited for applications requiring secondary output cavities coupled to inductive output tubes.